{"id":256814,"title":"Biologic drugs (Schedule D drugs) – Division 4 proposed regulatory amendments: Notice to stakeholders - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T15:48:25.295000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html","snippet":"Biologic drugs (Schedule D drugs) – Division 4 proposed regulatory amendments: Notice to stakeholders - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the…","rawSnapshotUrl":"/api/snapshots/raw/256814","browseUrl":"https://replay.healtharchive.ca/job-1/20250418154825/https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html#ha_snapshot=256814","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}